GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

Intel's 2026 turnaround relies on AI trends, foundry growth, and competitive products. Learn what's at stake and what this ...

Rival railroads claim they’ve found many flaws in the Union Pacific-Norfolk Southern merger application and are asking the ...

Verastem, Inc. shifts focus to VS-7375 for KRAS G12D tumors after ending RAMP-203. Click to learn about VSTM's key catalysts ...